Skip to main content

$0.550 0.010 (1.85%)

High

$0.56

Low

$0.54

Trades

245

Turnover

$454,189

Volume

827,047
30 June 2023 at 4:59pm
Register to track OPT and receive email alerts.
Subject
OPT Ann: S&P DJI Announces March 2022 Quarterly Rebalance

OPT Ann: Opthea appoints Dr.Joel Naor M.D as Chief Medical Officer

OPT Ann: Change in substantial holding

OPT Ann: Opthea Half Year Report and Accounts

OPT Ann: Change in substantial holding

OPT Ann: Change in substantial holding

OPT Ann: Becoming a substantial holder

OPT Ann: Change in substantial holding

OPT Ann: Angiogenesis 2022 -Prof Cheung presentation of PCV data

OPT Ann: Opthea data for OPT-302 in patients with PVC as presented

OPT Ann: Opthea present at SVB Leerink Global Healthcare Conference

OPT Ann: Opthea presents at the Angiogenesis 2022 Conference

OPT Ann: Change in substantial holding

OPT Ann: Change in substantial holding

OPT Ann: Change in substantial holding

OPT Ann: Change in substantial holding

OPT Ann: Opthea announces establishment of ATM Equity Program

OPT Ann: Form F-3 Registration Statement

OPT Ann: Becoming a substantial holder

OPT Ann: Ceasing to be a substantial holder

OPT Ann: Becoming a substantial holder

OPT Ann: Ceasing to be a substantial holder

OPT Ann: Opthea Receives A$6.6m R&D Tax Incentive

OPT Ann: Becoming a substantial holder

OPT Ann: Ceasing to be a substantial holder

OPT Ann: Change in substantial holding

OPT Ann: Becoming a substantial holder

OPT Ann: Opthea to present at H.C. Wainwright BIOCONNECT conference

OPT Ann: Opthea appoints CCO to lead Commercialization of OPT-302

OPT Ann: Ceasing to be a substantial holder

OPT Ann: Becoming a substantial holder

OPT Ann: Ceasing to be a substantial holder

OPT Ann: Appendix 2A

OPT Ann: Cleansing Notice

OPT Ann: Change in substantial holding

OPT Ann: Notification regarding unquoted securities - OPT

OPT Ann: Change of Director's Interest Notice-MB

OPT Ann: Notification regarding unquoted securities - OPT

OPT Ann: Change of Director's Interest Notice -JH

OPT Ann: Change of Director's Interest Notice -JR

OPT Ann: Notification regarding unquoted securities - OPT

OPT Ann: Change in substantial holding

OPT Ann: Change in substantial holding

OPT Ann: Change in substantial holding

OPT Ann: Appendix 2A

OPT Ann: Cleansing Notice

OPT Ann: Opthea Granted Chinese Patent Covering OPT-302

OPT Ann: Change in substantial holding

OPT Ann: Becoming a substantial holder

OPT Ann: Cleansing Notice update

Register to track OPT and receive email alerts.

Similar Companies

CSL ...
CSL
CUV
IMM
IMU
MSB
PAR
PYC
RAC
TLX